ATE119916T1 - Verfahren zur enzymatischen herstellung von grf(1-44)nh2. - Google Patents

Verfahren zur enzymatischen herstellung von grf(1-44)nh2.

Info

Publication number
ATE119916T1
ATE119916T1 AT91120820T AT91120820T ATE119916T1 AT E119916 T1 ATE119916 T1 AT E119916T1 AT 91120820 T AT91120820 T AT 91120820T AT 91120820 T AT91120820 T AT 91120820T AT E119916 T1 ATE119916 T1 AT E119916T1
Authority
AT
Austria
Prior art keywords
grf
enzymatic production
leu
prepared
recombinant dna
Prior art date
Application number
AT91120820T
Other languages
English (en)
Inventor
Arthur Martin Felix
Edgar Philip Heimer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE119916T1 publication Critical patent/ATE119916T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT91120820T 1990-12-10 1991-12-04 Verfahren zur enzymatischen herstellung von grf(1-44)nh2. ATE119916T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62444590A 1990-12-10 1990-12-10

Publications (1)

Publication Number Publication Date
ATE119916T1 true ATE119916T1 (de) 1995-04-15

Family

ID=24502049

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91120820T ATE119916T1 (de) 1990-12-10 1991-12-04 Verfahren zur enzymatischen herstellung von grf(1-44)nh2.

Country Status (13)

Country Link
US (1) US5563044A (de)
EP (1) EP0490249B1 (de)
JP (1) JPH05178893A (de)
AT (1) ATE119916T1 (de)
AU (1) AU644032B2 (de)
CA (1) CA2057269A1 (de)
DE (1) DE69108192T2 (de)
DK (1) DK0490249T3 (de)
IE (1) IE67052B1 (de)
IL (1) IL100261A (de)
NZ (1) NZ240895A (de)
PH (1) PH30442A (de)
ZA (1) ZA919655B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7338294A (en) * 1993-07-20 1995-02-20 Bionebraska, Inc. Method for endomodification of proteins
US5512459A (en) * 1993-07-20 1996-04-30 Bionebraska, Inc. Enzymatic method for modification or recombinant polypeptides
DE102005046113A1 (de) 2005-09-27 2007-03-29 Sanofi-Aventis Deutschland Gmbh Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen
NZ570886A (en) 2008-08-29 2011-05-27 Nz Inst Plant & Food Res Ltd Method and compositions to reduce polygalacturonase expression in plants for increasing storage-life of fruit
BR112012019992A2 (pt) 2010-02-11 2020-08-18 F. Hoffmann-La Roche Ag. conjugados de igf-i poli (etileno glicol)

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2838659C2 (de) * 1978-09-05 1981-07-16 Bio-Melktechnik Swiss Hoefelmayer & Co, Niederteufen, Aargau Schlauchanordnung für eine Viertelgemelksmaschine
US4618598A (en) * 1982-04-12 1986-10-21 Duke University Method of regulating hormone function or release
US4517181A (en) * 1982-09-15 1985-05-14 The Salk Institute For Biological Studies Mammalian PGRF
US4703035A (en) * 1982-10-04 1987-10-27 The Salk Institute For Biological Studies Human pancreatic GRF amidated fragments
US4563352A (en) * 1982-10-04 1986-01-07 The Salk Institute For Biological Studies Human pancreatic GRF
US4529595A (en) * 1983-01-13 1985-07-16 The Salk Institute For Biological Studies GRF Analogs
US4595676A (en) * 1983-04-26 1986-06-17 The Salk Institute For Biological Studies Rat hypothalamic GRF
US4728726A (en) * 1982-10-04 1988-03-01 The Salk Institute For Biological Studies GRF analogs IIIb
US4518586A (en) * 1983-01-13 1985-05-21 The Salk Institute For Biological Studies GRF Analogs III
IL70530A (en) * 1983-01-13 1986-09-30 Salk Inst For Biological Studi Synthetic peptides having growth hormone releasing factor activity and compositions containing them
US4581168A (en) * 1983-02-21 1986-04-08 Sanofi Synthesis of hpGRF (Somatocrinin) in liquid phase and intermediate peptides
US4704450A (en) * 1983-02-21 1987-11-03 Sanofi Synthesis of hpGRF(Somatocrinin) in liquid phase and intermediate peptides
ATE53220T1 (de) * 1983-03-07 1990-06-15 Hoffmann La Roche Polypeptide.
US4732972A (en) * 1983-03-07 1988-03-22 Hoffmann-La Roche Inc. Polypeptides having growth hormone releasing activity
US4628043A (en) * 1983-04-26 1986-12-09 The Salk Institute For Biological Studies Hypothalamic GRF agonists
DE3327007A1 (de) * 1983-07-27 1985-02-07 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit einem saeureamid-carboxyterminus
US4605643A (en) * 1984-03-02 1986-08-12 The Salk Institute For Biological Studies Ovine GRF
US4585756A (en) * 1983-10-12 1986-04-29 The Salk Institute For Biological Studies Bovine GRF
US4610976A (en) * 1983-08-29 1986-09-09 The Salk Institute For Biological Studies Porcine GRF
US4626523A (en) * 1983-09-13 1986-12-02 The Salk Institute For Biological Studies GRF analogs II
US4617149A (en) * 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs
US4528190A (en) * 1983-10-25 1985-07-09 The Salk Institute For Biological Studies GRF Analogs IV
US4562175A (en) * 1984-02-03 1985-12-31 Ding Chang Synthetic peptides
US4649039A (en) * 1984-07-03 1987-03-10 E. I. Du Pont De Nemours And Company Radiolabeling of methionine-containing proteins and peptides
US4649131A (en) * 1984-09-24 1987-03-10 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
US4622312A (en) * 1984-09-24 1986-11-11 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
US4734399A (en) * 1985-08-06 1988-03-29 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
US4689318A (en) * 1985-08-29 1987-08-25 The Salk Institute For Biological Studies GRF analogs
US4783524A (en) * 1985-09-17 1988-11-08 Monsanto Company Growth factors
US4784987A (en) * 1987-01-13 1988-11-15 The Salk Institute For Biological Studies GRF analogs VI
US4914189A (en) * 1987-02-05 1990-04-03 The Adminstrators Of The Tulane Educational Fund Synthetic GHRH analogs
US5002931A (en) * 1987-05-22 1991-03-26 The Salk Institute For Biological Studies GRF analogs VII
GB8829432D0 (en) * 1988-12-15 1989-02-01 Celltech Ltd Enzymatic process

Also Published As

Publication number Publication date
IE914276A1 (en) 1992-06-17
IL100261A (en) 1996-05-14
JPH05178893A (ja) 1993-07-20
DK0490249T3 (da) 1995-05-29
CA2057269A1 (en) 1992-06-11
US5563044A (en) 1996-10-08
IE67052B1 (en) 1996-02-21
PH30442A (en) 1997-05-09
AU8896491A (en) 1992-06-11
NZ240895A (en) 1993-08-26
AU644032B2 (en) 1993-12-02
DE69108192T2 (de) 1995-07-20
DE69108192D1 (de) 1995-04-20
EP0490249A1 (de) 1992-06-17
IL100261A0 (en) 1992-09-06
EP0490249B1 (de) 1995-03-15
ZA919655B (en) 1992-08-26

Similar Documents

Publication Publication Date Title
DE69020794D1 (de) Enzymatische Entfernung einer aminoterminalen Proteinsequenz.
DE59108934D1 (de) Verfahren zur Herstellung von L-Phosphinothricin durch eine gekoppelte enzymatische Reaktion
DE69717356D1 (de) Verfahren zur Herstellung von Heteroübergang-Bipolartransistoren mit hoher Verstärkung
DE69428165D1 (de) Teilhydrolysat aus Milcheiweiss und Verfahren zu dessen Herstellung
ATE68830T1 (de) Verfahren zur erhoehung der ausbeute von heterologen proteinen, produziert durch zuechtung von rekombinanten bakterien.
ATE124418T1 (de) Collagen-zubereitungen und verfahren zur herstellung davon.
ATE255604T1 (de) Verfahren zur herstellung von polyalkenaminen
DE68919246D1 (de) Verfahren zur Herstellung von Aminosäuren.
DE69011880D1 (de) Verfahren zur Herstellung von L-Aminosäuren durch Fermentation.
ATE119916T1 (de) Verfahren zur enzymatischen herstellung von grf(1-44)nh2.
ATE321773T1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
ATE227307T1 (de) Verfahren zur herstellung modifizierten proteine
DE69416018D1 (de) Verfahren zur Herstellung von Alkoxyiminoacetamid-Verbindungen
DE69431824D1 (de) Verfahren zur Herstellung von Schwefelhaltigen Imidazolderivaten und erhaltene Zwischenprodukte
DE68926922D1 (de) Verfahren zur Herstellung von L-alpha-Aminosäuren
DE69109510D1 (de) Verfahren zur Herstellung von Glycin.
ATE118008T1 (de) Verfahren zur herstellung von aminomethanphosphonsäure und aminomethyl- phosphinsäuren.
ATE30155T1 (de) Verfahren zur herstellung von azetidinsulfonsaeuren.
DE69024999D1 (de) Verfahren zur Herstellung von 2-Oxindol-1-carboxamiden
DE69021001D1 (de) Enzymatisches Verfahren zur Herstellung von L-Serin.
ATE200776T1 (de) Verfahren zur herstellung von 2,4,5-tribrompyrrol-3-carbonitril
DE69016380D1 (de) Verfahren zur Herstellung von molluskiziden 2,4,5-Tribrompyrrol-3-Carbonitrilen.
ATE124053T1 (de) Verfahren zur herstellung von tripeptiden.
ATE198737T1 (de) Verfahren zur herstellung von n-(2-carboxy-5- chlor-phenyl)glycin
AU643773B2 (en) Growth hormone releasing factor analogs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee